{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:55:03Z","timestamp":1776318903768,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08567, JP25K11691"],"award-info":[{"award-number":["JP22K08567, JP25K11691"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Recent reports have suggested an association between the pathogenesis of systemic lupus erythematosus (SLE) and various adipokines secreted by adipocytes. However, the impact of obesity on the susceptibility to SLE relapses remains unclear. This study investigated the association between obesity and relapse in patients with SLE using a large, multicenter cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients enrolled in LUNA, a nationwide, multicenter SLE registry in Japan, with a body mass index (BMI) \u2265 18.5 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      were included in the study. Participants were divided into two groups: the obese group (BMI \u2265 25 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) and the normal weight group (18.5 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      \u2264 BMI &amp;lt; 25 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ). The one-year relapse rate after LUNA registration was compared between the two groups. Relapses were defined as an increase in glucocorticoid dosage during follow-up. A multivariate analysis was performed using generalized linear models adjusted for age, sex, disease duration, education level, glycated hemoglobin level, disease activity (Systemic Lupus Erythematosus Disease Activity Index), organ damage (Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index), current prednisolone (PSL) dose, past maximum PSL dose, calcineurin inhibitor use, and incretin-related drug use as covariates. Furthermore, a sensitivity analysis was performed using the same statistical model and covariate adjustments to reclassify participants into the overweight (BMI \u2265 25 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and &amp;lt; 30 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) and non-overweight (BMI \u2265 18.5 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and &amp;lt; 25 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      or BMI \u2265 30 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 1, 134 patients, 909 were classified as normal weight and 225 as obese. The multivariate analysis showed that obesity significantly reduced relapse rates (odds ratio [OR] 0.52, 95% confidence interval [CI] 0.30-0.90,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.02). The sensitivity analysis revealed that overweight was an independent factor associated with a reduced risk of SLE relapses, with an OR lower than that for obesity in the primary analysis (OR 0.43, 95% CI 0.22\u20130.82,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with mild obesity had lower relapse rates than those with normal BMI. The findings suggest that metabolic status may influence the disease course of SLE. Appropriate weight management guidance, including avoiding excessive dietary restriction, may help prevent SLE relapses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1781933","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:25:03Z","timestamp":1776317103000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The relationship between obesity and disease relapse in systemic lupus erythematosus: a retrospective cohort study using the LUNA registry"],"prefix":"10.3389","volume":"17","author":[{"given":"Naoki","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]},{"name":"Clinical Laboratory Department, Yokohama City University Hospital","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Hidekawa","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiga","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Takase-Minegishi","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Ohno","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Yokohama City University Medical Center","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yajima","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa Medical University","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ei","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Kochi Medical School, Kochi University","place":["Nankoku, Japan"]},{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences","place":["Okayama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences","place":["Okayama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shimane University Faculty of Medicine","place":["Izumo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences","place":["Nagasaki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Takatani","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences","place":["Nagasaki, Japan"]},{"name":"Rheumatic Disease Center, Sasebo Chuo Hospital","place":["Sasebo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kajiyama","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University","place":["Saitama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine","place":["Fukushima, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Shimojima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine","place":["Matsumoto, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Yokohama Rosai Hospital","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kida","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine","place":["Kyoto, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tokyo Kyosai Hospital","place":["Tokyo, Japan"]},{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine","place":["Kobe, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kakogawa Central City Hospital","place":["Kakogawa, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Katsushima","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Umekita","sequence":"additional","affiliation":[{"name":"Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki","place":["Miyazaki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Miyake","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Tenri Hospital","place":["Tenri, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Yokohama Minami Kyosai Hospital","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ida","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Chiba University Hospital","place":["Chiba, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Dokkyo Medical University","place":["Tochigi, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","article-title":"Systemic lupus erythematosus","volume-title":"StatPearls","author":"Justiz Vaillant","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: Diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22932","article-title":"Impact of obesity on remission and disease activity in rheumatoid arthritis: A systematic review and meta-analysis","volume":"69","author":"Liu","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620954556","article-title":"Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort","volume":"8","author":"Greuter","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05731-6","article-title":"Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis","volume":"40","author":"Gigante","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids","volume":"70","author":"McMahon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.21400","article-title":"Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus","volume":"52","author":"Oeser","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23576","article-title":"Obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus","volume":"71","author":"Patterson","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ahj.2008.02.014","article-title":"Body mass index and mortality in heart failure: a meta-analysis","volume":"156","author":"Oreopoulos","year":"2008","journal-title":"Am Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjcard.2012.02.050","article-title":"The obesity paradox in men versus women with systolic heart failure","volume":"110","author":"Clark","year":"2012","journal-title":"Am J Cardiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-10-0599","article-title":"Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan","volume":"74","author":"Hamaguchi","year":"2010","journal-title":"Circ J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000772","article-title":"Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study","volume":"9","author":"Sada","year":"2022","journal-title":"Lupus Sci Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.21203\/rs.3.rs-1009539\/v1","article-title":"Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study","volume":"24","author":"Abe","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13075-021-02466-2","article-title":"Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study","volume":"23","author":"Miyawaki","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01055","article-title":"Changes in nutritional status impact immune cell metabolism and function","volume":"9","author":"Alwarawrah","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1253\/circj.66.987","article-title":"New criteria for 'obesity disease' in Japan","volume":"66","year":"2002","journal-title":"Circ J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10067-018-4336-3","article-title":"The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR)","volume":"38","author":"Teh","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"B23","article-title":"BMI classification percentile and cut off points","volume-title":"StatPearls","author":"Weir","year":"2025"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.118.313777","article-title":"Myonectin is an exercise-induced myokine that protects the heart from ischemia-reperfusion injury","volume":"123","author":"Otaka","year":"2018","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","article-title":"The obesity paradox in cancer: a review","volume":"18","author":"Lennon","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14232725","article-title":"Obesity: Friend or foe in Sj\u00f6gren's syndrome patients","volume":"14","author":"Mezei","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10753-016-0452-x","article-title":"Role of leptin and SOCS3 in inhibiting the type I interferon response during obesity","volume":"40","author":"Ter\u00e1n-Cabanillas","year":"2017","journal-title":"Inflammation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1038\/s41467-023-42432-x","article-title":"Obesity dysregulates the pulmonary antiviral immune response","volume":"14","author":"Almond","year":"2023","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00637.x","article-title":"Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C*","volume":"12","author":"Seyam","year":"2005","journal-title":"J Viral Hepat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of immunometabolism and implications for metabolic health and disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646423","article-title":"Nutritional effects on T-cell immunometabolism","volume":"47","author":"Cohen","year":"2017","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1503559","article-title":"Body weight in systemic lupus erythematosus is associated with disease activity and the adaptive immune system, independent of type I IFN","volume":"16","author":"Teruya","year":"2025","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/srep11296","article-title":"Adiponectin exacerbates collagen-induced arthritis via enhancing Th17 response and prompting RANKL expression","volume":"5","author":"Sun","year":"2015","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200706","article-title":"Resistin-like molecule \u03b1 promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation","volume":"190","author":"Osborne","year":"2013","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.018","article-title":"Adiponectin and inflammation: consensus and controversy","volume":"121","author":"Fantuzzi","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4468","article-title":"The potential of adiponectin in driving arthritis","volume":"176","author":"Ehling","year":"2006","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2006.02.001","article-title":"Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells","volume":"134","author":"Ogunwobi","year":"2006","journal-title":"Regul Pept"},{"key":"B39","article-title":"Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus","volume":"33","author":"Sada","year":"2006","journal-title":"J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"key":"B43","volume-title":"Guideline for the management of systemic lupus erythematosus 2019","year":"2019"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781933\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:25:04Z","timestamp":1776317104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781933\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1781933"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1781933","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1781933"}}